Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000549749 | SCV000643072 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000714021 | SCV000844684 | uncertain significance | not provided | 2018-04-18 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293184 | SCV001434182 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Prevention |
RCV004537984 | SCV004120426 | uncertain significance | TTN-related disorder | 2023-10-09 | criteria provided, single submitter | clinical testing | The TTN c.37502C>T variant is predicted to result in the amino acid substitution p.Pro12501Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.035% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179523473-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |